左从林

All filings by 左从林 on record concern 昭衍新药, in the capacity of board member. In total, 9 filings cover trades dated from 27 September 2021 to 3 November 2023.

Sales make up the whole of the open-market record (9 sales, €43.4M). So far in 2023, the count stands at no purchases and 6 sales.

Most recently, on 3 November 2023, the filings show an open-market sale worth €1.7M in 昭衍新药. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.